| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191361C Carrot anti-freeze polypeptides |
| 03/02/2005 | CN1191360C Modified clotting factor VIII |
| 03/02/2005 | CN1191357C Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 03/02/2005 | CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line |
| 03/02/2005 | CN1191273C Long lasting insulinotropic peptides |
| 03/02/2005 | CN1191272C Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 03/02/2005 | CN1191271C Thymic peptide fusion protein as one new interferon and its prepn. |
| 03/02/2005 | CN1191270C Cellulose binding domain |
| 03/02/2005 | CN1191091C Novel preventives/remedies for immunopathy |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/01/2005 | US6861578 Method for plant protection against insects or nematodes by transformation with a nucleic acid encoding equistatin |
| 03/01/2005 | US6861576 Microspore-specific promoter and method for obtaining hybrid plants |
| 03/01/2005 | US6861574 Sodium/proton antiporter gene |
| 03/01/2005 | US6861573 Comprises nucleotide sequences coding glycine rich polypeptide for use in generating genetically engineered disease resistant plants; biological pest control |
| 03/01/2005 | US6861511 Detection and quantification of neu related proteins in the biological fluids of humans |
| 03/01/2005 | US6861510 Immunogenic compositions against gastrin peptides |
| 03/01/2005 | US6861509 Antibodies to Ret and RetL3 |
| 03/01/2005 | US6861508 Polypeptide for use in the treatment of cancer |
| 03/01/2005 | US6861507 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
| 03/01/2005 | US6861506 Compositions and methods for the treatment and diagnosis of breast cancer |
| 03/01/2005 | US6861505 Method for recovering soluble protein |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861404 Therapies for chronic renal failure |
| 03/01/2005 | US6861403 Generating soluble active recombinat proteins; obtain vector, insert preferential binding domain into vector, transform cell, propagate induce expresion of recombinant protein |
| 03/01/2005 | US6861256 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 03/01/2005 | US6861253 Polypeptide inducing antibodies neutralizing HIV |
| 03/01/2005 | US6861247 Salmonella secreted proteins and uses thereof |
| 03/01/2005 | US6861246 L-lysine-producing corynebacteria and process for the preparation of lysine |
| 03/01/2005 | US6861245 Production of heterologous polypeptides from freshwater caulobacter |
| 03/01/2005 | US6861237 Production of heterologous polypeptides in yeast |
| 03/01/2005 | US6861236 Harvesting antibiotic peptides comprising transport protein leader sequences |
| 03/01/2005 | US6861231 Immunoglobulin for use diagnostic tool in genetic engineering |
| 03/01/2005 | US6861228 Modulating Robo: ligand interactions |
| 03/01/2005 | US6861227 For diagnosing disorders related to the immune system; therapy and prophylaxis |
| 03/01/2005 | US6861226 Human endometrial specific steroid-binding factor I, II and III |
| 03/01/2005 | US6861212 NANBV diagnostics and vaccines |
| 03/01/2005 | US6861059 Administering DP-107 or a pharmaceutically acceptable derivative thereof along with at least one therapeutic agent; synergistic |
| 03/01/2005 | US6861058 Relieving pain related to muscle activity or contracture, antispasmodic |
| 03/01/2005 | US6861057 Immunogenic β-amyloid peptide |
| 03/01/2005 | US6861054 suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 03/01/2005 | CA2346257C Method for obtaining active .beta.-ngf |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 03/01/2005 | CA2085719C Process for obtaining insulin-containing solutions |
| 02/28/2005 | CA2479474A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same, and uses thereof |
| 02/28/2005 | CA2438753A1 Genes involved in biofilm formation by the pathogenic yeast candida albicans |
| 02/25/2005 | CA2476143A1 Method for inducing cytotoxic t lymphocyte |
| 02/24/2005 | WO2005017237A2 Apparatus and method for the selective assembly of protein |
| 02/24/2005 | WO2005017198A2 Surface display expression system |
| 02/24/2005 | WO2005017188A2 Fusion proteins with a membrane translocating sequence and methods of using same to inhibit an immune response |
| 02/24/2005 | WO2005017174A2 Process for the purification of recombinant polypeptides |
| 02/24/2005 | WO2005017170A2 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 02/24/2005 | WO2005017168A1 Expression of human milk proteins in transgenic plants |
| 02/24/2005 | WO2005017163A2 Phenotypic knockout of cell-surface proteins |
| 02/24/2005 | WO2005017162A2 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 02/24/2005 | WO2005017161A2 Chimeric peptides for the regulation of gtpases |
| 02/24/2005 | WO2005017160A2 Mobilization of hematopoietic cells |
| 02/24/2005 | WO2005017158A1 Nucleic acids from rice conferring resistance to bacterial blight disease caused by xanthomonas spp. |
| 02/24/2005 | WO2005017156A1 A NEW CLASS OF α2δ CALCIUM CHANNEL SUBUNITS |
| 02/24/2005 | WO2005017155A1 Fucose transporter |
| 02/24/2005 | WO2005017151A1 End-deficient mutant of ip3 receptor protein inducing apoptosis |
| 02/24/2005 | WO2005017143A1 Diagnosis and treatment of neurodegenerative disorders, involving the microtubule associated protein tau (mapt) gene |
| 02/24/2005 | WO2005017133A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | WO2005017131A2 Methods for the differentiation of human stem cells |
| 02/24/2005 | WO2005017125A2 Method for isolation and replication of infectious human hepatitis-c virus |
| 02/24/2005 | WO2005017123A2 Mptens as modifiers of the pten pathway and methods of use |
| 02/24/2005 | WO2005017115A2 Cord blood-derived hematopoietic progenitor cells |
| 02/24/2005 | WO2005017114A2 Method of increasing metabolism and stress tolerance in a plant |
| 02/24/2005 | WO2005017107A2 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | WO2005017102A2 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 02/24/2005 | WO2005017101A2 Avian adenoassociated virus (aaav) and uses thereof |
| 02/24/2005 | WO2005017099A2 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/24/2005 | WO2005017096A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016966A2 Intron fusion proteins, and methods of identifying and using same |
| 02/24/2005 | WO2005016965A1 Modulators of the potassium channels twik-1, task-1, girk1, sk2 or pcn1, used to treat arrhythmia, coronary heart disease or hypertension |
| 02/24/2005 | WO2005016964A2 Canine specific growth hormone releasing hormone |
| 02/24/2005 | WO2005016963A2 Heparin binding veger-3 ligands |
| 02/24/2005 | WO2005016962A2 Compositions and methods for the treatment of immune related diseases |
| 02/24/2005 | WO2005016961A1 Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens |
| 02/24/2005 | WO2005016960A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | WO2005016957A1 REAGENT FOR AMPLIFYING AMYLOID FIBROSIS OF AMYLOID β-PROTEIN |
| 02/24/2005 | WO2005016955A2 Nogo receptor antagonists |
| 02/24/2005 | WO2005016953A2 Antagonistic analogs of gh-rh (2003) |
| 02/24/2005 | WO2005016952A2 Polyvalent immunogen |
| 02/24/2005 | WO2005016414A2 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 02/24/2005 | WO2005016378A1 An immunodeficiency virus (hiv) dna vaccine and to the process of preparation thereof |
| 02/24/2005 | WO2005016371A1 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES |
| 02/24/2005 | WO2005016367A1 Therapeutic preparation for hematopoietic disease |
| 02/24/2005 | WO2005016283A2 Peptides for enhanced cell attachment and growth |
| 02/24/2005 | WO2005016266A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | WO2005016247A2 Dna sequences, peptides, antibodies and vaccines for prevention and treatment of sars |
| 02/24/2005 | WO2005016246A2 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 02/24/2005 | WO2005016241A2 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/24/2005 | WO2005016233A2 Botulinum neurotoxin b receptors and use thereof |
| 02/24/2005 | WO2005016232A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |